Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers
The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iro...
Saved in:
Published in | Advanced healthcare materials Vol. 4; no. 8; p. 1246 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
03.06.2015
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iron(III) trimesate nanoparticles MIL-100(Fe) with heparin, a biopolymer associated with longer-blood circulation times is reported. First, the coated nanoparticles showed intact crystalline structure and porosity with improved colloidal stability under simulated physiological conditions, preserving in addition its encapsulation and controlled release capacities. The effect of the heparin coating on the nanoMOF interactions with the biological environment is evaluated through cell uptake, cytotoxicity, oxidative stress, cytokine production, complement activation, and protein adsorption analysis. These results confirmed that the heparin coating endowed the nanoMOFs with improved biological properties, such as reduced cell recognition, lack of complement activation, and reactive oxygen species production. Overall, the ability to coat the surface of the nanoMOFs using a simple and straight-forward approach could be taken as a way to enhance the versatility and, thus, the potential of porous MOF nanoparticles in biomedicine. |
---|---|
AbstractList | The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity is still a major challenge. Here a simple, fast, and biofriendly method for the external functionalization of the benchmarked mesoporous iron(III) trimesate nanoparticles MIL-100(Fe) with heparin, a biopolymer associated with longer-blood circulation times is reported. First, the coated nanoparticles showed intact crystalline structure and porosity with improved colloidal stability under simulated physiological conditions, preserving in addition its encapsulation and controlled release capacities. The effect of the heparin coating on the nanoMOF interactions with the biological environment is evaluated through cell uptake, cytotoxicity, oxidative stress, cytokine production, complement activation, and protein adsorption analysis. These results confirmed that the heparin coating endowed the nanoMOFs with improved biological properties, such as reduced cell recognition, lack of complement activation, and reactive oxygen species production. Overall, the ability to coat the surface of the nanoMOFs using a simple and straight-forward approach could be taken as a way to enhance the versatility and, thus, the potential of porous MOF nanoparticles in biomedicine. |
Author | Alonso, Maria J González-Fernández, África Lozano, Maria Victoria Hidalgo, Tania Horcajada, Patricia Guillevic, Mazheva Bellido, Elena Simón-Vázquez, Rosana Santander-Ortega, Manuel J Serre, Christian |
Author_xml | – sequence: 1 givenname: Elena surname: Bellido fullname: Bellido, Elena organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France – sequence: 2 givenname: Tania surname: Hidalgo fullname: Hidalgo, Tania organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France – sequence: 3 givenname: Maria Victoria surname: Lozano fullname: Lozano, Maria Victoria organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France – sequence: 4 givenname: Mazheva surname: Guillevic fullname: Guillevic, Mazheva organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France – sequence: 5 givenname: Rosana surname: Simón-Vázquez fullname: Simón-Vázquez, Rosana organization: Immunology, Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Vigo (IBIV), Universidad de Vigo, Campus Lagoas Marcosende, 36310, Vigo, Pontevedra, Spain – sequence: 6 givenname: Manuel J surname: Santander-Ortega fullname: Santander-Ortega, Manuel J organization: Nanobiofar. Center for Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Av. Barcelona s/n, Campus Vida, 15706, Santiago de Compostela, Spain – sequence: 7 givenname: África surname: González-Fernández fullname: González-Fernández, África organization: Immunology, Biomedical Research Center (CINBIO) and Institute of Biomedical Research of Vigo (IBIV), Universidad de Vigo, Campus Lagoas Marcosende, 36310, Vigo, Pontevedra, Spain – sequence: 8 givenname: Christian surname: Serre fullname: Serre, Christian organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France – sequence: 9 givenname: Maria J surname: Alonso fullname: Alonso, Maria J organization: Nanobiofar. Center for Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Av. Barcelona s/n, Campus Vida, 15706, Santiago de Compostela, Spain – sequence: 10 givenname: Patricia surname: Horcajada fullname: Horcajada, Patricia organization: Institut Lavoisier, UMR CNRS 8180, Université de Versailles Saint-Quentin-en-Yvelines, 45 Av. des Etats-Unis, 78035, Versailles cedex, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25771896$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j01LAzEYhIMottZePUr-wNbkTZPd9SbFLyh40XPJJu-2qbvJ8mZL8d9b_JjLMPDMwFyx85giMnYjxUIKAXfW7_oFCLkUotT6jE1B1lCA0fWEzXPei5OMlqaSl2wCuixlVZsp27_gYCnEAuM2RERCz3vMaUiUDpkHSvGUR9sVibY2Bsdbsj0eE33yaGM6lcfgOsz3fExHS57nEW037rinw_YHcZYoIOVrdtHaLuP8z2fs4-nxffVSrN-eX1cP68Ity1IXvm5UDcbUlWmUkOBKAaAUoHQeNLaN8kIrrY31jZZKCAtgnGqtlrLFSsOM3f7uDoemR78ZKPSWvjb_p-EbwStb4A |
CitedBy_id | crossref_primary_10_1016_j_ccr_2019_04_006 crossref_primary_10_1039_C8TB03192D crossref_primary_10_1049_bsb2_12012 crossref_primary_10_1039_C8RA03616K crossref_primary_10_1021_acs_inorgchem_0c03550 crossref_primary_10_1016_j_ijpx_2023_100161 crossref_primary_10_3389_fbioe_2020_01027 crossref_primary_10_1016_j_cclet_2022_05_021 crossref_primary_10_1039_C7CC09739E crossref_primary_10_1016_j_jece_2023_109967 crossref_primary_10_1080_16583655_2021_1996944 crossref_primary_10_1021_acs_molpharmaceut_8b01185 crossref_primary_10_1002_adhm_201900761 crossref_primary_10_1016_j_ijpharm_2021_121230 crossref_primary_10_3390_nano11030722 crossref_primary_10_1002_cmdc_201900596 crossref_primary_10_1016_j_aej_2023_11_086 crossref_primary_10_1021_acsinfecdis_3c00131 crossref_primary_10_1039_D3NR05776C crossref_primary_10_1080_17425247_2022_2064450 crossref_primary_10_1016_j_nanoms_2021_12_003 crossref_primary_10_1039_C9NR08127E crossref_primary_10_1021_acs_cgd_0c01090 crossref_primary_10_1021_acs_chemmater_3c01495 crossref_primary_10_1039_D3MD00416C crossref_primary_10_1016_j_partic_2022_03_002 crossref_primary_10_1002_smll_202005064 crossref_primary_10_1016_j_reactfunctpolym_2024_105918 crossref_primary_10_1016_j_biomaterials_2018_06_007 crossref_primary_10_1016_j_ejpb_2018_08_013 crossref_primary_10_1039_C9RA06678K crossref_primary_10_1021_acsami_0c20070 crossref_primary_10_1016_j_ijpharm_2020_119281 crossref_primary_10_1016_j_ijpharm_2022_121647 crossref_primary_10_2174_1573413719666230413084140 crossref_primary_10_1007_s10876_022_02348_w crossref_primary_10_1016_j_ijpharm_2016_08_010 crossref_primary_10_1021_acsami_7b10064 crossref_primary_10_1016_j_addr_2022_114496 crossref_primary_10_1002_ente_202100212 crossref_primary_10_1016_j_biomaterials_2021_120951 crossref_primary_10_1039_C8TB00072G crossref_primary_10_1016_j_colsurfa_2019_02_025 crossref_primary_10_1039_C9SC03802G crossref_primary_10_1039_D3BM00758H crossref_primary_10_1021_acsami_1c01089 crossref_primary_10_3390_jfb14060319 crossref_primary_10_1007_s40820_023_01180_9 crossref_primary_10_1002_adma_202005215 crossref_primary_10_1016_j_ccr_2018_09_009 crossref_primary_10_1016_j_envres_2023_115589 crossref_primary_10_1002_adfm_201909062 crossref_primary_10_1002_adma_201606134 crossref_primary_10_1002_smll_202206211 crossref_primary_10_1039_D3TB00027C crossref_primary_10_1039_D3SC03659F crossref_primary_10_1002_smll_201500802 crossref_primary_10_1002_cplu_202000496 crossref_primary_10_3390_ma14133652 crossref_primary_10_1039_D1CS00918D crossref_primary_10_1016_j_ijbiomac_2023_127120 crossref_primary_10_1021_acsmaterialslett_2c01175 crossref_primary_10_1016_j_ccr_2015_08_008 crossref_primary_10_1016_j_ecoenv_2022_114275 crossref_primary_10_1016_j_chempr_2017_06_007 crossref_primary_10_1039_D3TB01819A crossref_primary_10_1039_D2TB02094G crossref_primary_10_1002_adtp_201800100 crossref_primary_10_3390_molecules25071598 crossref_primary_10_1016_j_biomaterials_2017_01_025 crossref_primary_10_3390_molecules25010185 crossref_primary_10_1021_acsnano_1c10942 crossref_primary_10_1021_acsami_2c05338 crossref_primary_10_1016_j_ccr_2020_213651 crossref_primary_10_1016_j_chempr_2023_09_016 crossref_primary_10_1039_C5TB01223F crossref_primary_10_1016_j_ccr_2021_213949 crossref_primary_10_1021_acsami_7b17756 crossref_primary_10_1039_D1CS00468A crossref_primary_10_1021_acs_energyfuels_1c00517 crossref_primary_10_1002_adfm_202312866 crossref_primary_10_3390_pharmaceutics12050437 crossref_primary_10_1021_acs_chemmater_6b00180 crossref_primary_10_1016_j_cclet_2019_11_036 crossref_primary_10_1039_C5TB02084K crossref_primary_10_1002_asia_201801462 crossref_primary_10_1016_j_poly_2018_08_057 crossref_primary_10_1039_C6TB01652A crossref_primary_10_1016_j_cclet_2022_107986 crossref_primary_10_1039_D2AY01230H crossref_primary_10_1016_j_engreg_2020_06_001 crossref_primary_10_1021_acsami_8b09872 crossref_primary_10_1002_smtd_202201413 crossref_primary_10_3390_polym11101627 crossref_primary_10_1021_acs_molpharmaceut_8b00292 crossref_primary_10_1002_adfm_201606314 crossref_primary_10_1016_j_ccr_2019_02_032 crossref_primary_10_1002_jccs_202300115 crossref_primary_10_1021_acsami_9b21692 crossref_primary_10_1038_s43586_024_00320_8 crossref_primary_10_1016_j_biomaterials_2018_12_029 crossref_primary_10_1016_j_jddst_2020_102217 crossref_primary_10_1039_C9CE00757A crossref_primary_10_1016_j_est_2022_105700 crossref_primary_10_1039_C6TB03101C crossref_primary_10_1016_j_carbpol_2019_115085 crossref_primary_10_1016_j_cej_2023_144400 crossref_primary_10_1016_j_actbio_2018_05_050 crossref_primary_10_1002_asia_202000815 crossref_primary_10_1016_j_rechem_2024_101414 crossref_primary_10_1016_j_chemosphere_2021_130717 crossref_primary_10_1039_D1TB02339J crossref_primary_10_1039_D3RA00930K crossref_primary_10_1021_acsami_1c21555 crossref_primary_10_1039_D1TB00981H crossref_primary_10_1021_acsami_0c21486 crossref_primary_10_1002_adfm_201908924 crossref_primary_10_1016_j_jddst_2022_103718 crossref_primary_10_3390_magnetochemistry6030039 crossref_primary_10_1039_D1SC04112F crossref_primary_10_3390_app10155194 crossref_primary_10_1002_smll_201704440 crossref_primary_10_1021_acs_chemmater_2c01190 crossref_primary_10_1016_j_cej_2021_129386 crossref_primary_10_1002_smll_201801900 crossref_primary_10_1155_2018_9780489 crossref_primary_10_1515_zna_2021_0175 crossref_primary_10_1016_j_ccr_2021_214393 crossref_primary_10_1016_j_poly_2021_115509 crossref_primary_10_1039_C9DT04804A crossref_primary_10_1002_adma_201707634 crossref_primary_10_1021_acs_biomac_9b00870 crossref_primary_10_1002_slct_202103519 crossref_primary_10_3390_pharmaceutics15051521 crossref_primary_10_1021_acsabm_3c00525 crossref_primary_10_1002_biot_202000005 crossref_primary_10_1021_acssuschemeng_8b05587 crossref_primary_10_1016_j_chemosphere_2022_134359 crossref_primary_10_1021_acs_cgd_2c01041 crossref_primary_10_1039_C7CS00041C crossref_primary_10_1016_j_pmatsci_2019_100579 crossref_primary_10_1002_anie_201707346 crossref_primary_10_3390_pharmaceutics14020378 crossref_primary_10_1016_j_jconrel_2017_12_033 crossref_primary_10_2217_nnm_2023_0164 crossref_primary_10_1016_j_chempr_2017_02_005 crossref_primary_10_1039_C6TB02025A crossref_primary_10_1002_smsc_202200044 crossref_primary_10_1016_j_ccr_2023_215335 crossref_primary_10_1007_s12274_020_3179_9 crossref_primary_10_1002_adma_201707365 crossref_primary_10_1016_j_ccr_2020_213212 crossref_primary_10_1021_acsnano_8b06287 crossref_primary_10_1016_j_tifs_2023_06_024 crossref_primary_10_1002_adhm_201600169 crossref_primary_10_1016_j_ccr_2018_08_010 crossref_primary_10_1007_s00216_019_02217_y crossref_primary_10_1039_C7NR06777A crossref_primary_10_1007_s11095_017_2253_9 crossref_primary_10_1016_j_cej_2019_123363 crossref_primary_10_1021_acsami_1c18055 crossref_primary_10_1021_acsbiomaterials_0c01600 crossref_primary_10_1016_j_ijbiomac_2023_124627 crossref_primary_10_1039_D0TB02804E crossref_primary_10_1002_adhm_201600296 crossref_primary_10_1002_ange_201707346 crossref_primary_10_1038_srep43099 crossref_primary_10_1002_marc_201900333 crossref_primary_10_1021_acsami_1c01460 crossref_primary_10_3390_pharmaceutics13111945 |
ContentType | Journal Article |
Copyright | 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Copyright_xml | – notice: 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/adhm.201400755 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2192-2659 |
ExternalDocumentID | 25771896 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 05W 0R~ 1OC 33P 53G 8-0 8-1 A00 AAESR AAHHS AAIHA AANLZ AASGY AAXRX AAZKR ABCUV ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFRAH AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB AZVAB BDRZF BFHJK BMXJE BRXPI C45 CGR CUY CVF D-A D-B DCZOG DRFUL DRMAN DRSTM EBD EBS ECM EIF EMOBN G-S HGLYW HZ~ KBYEO LATKE LEEKS LITHE LOXES LUTES LYRES MEWTI MXFUL MXMAN MXSTM MY. MY~ NPM O9- OVD P2W PQQKQ ROL SUPJJ SV3 TEORI WBKPD WOHZO WXSBR WYJ ZZTAW |
ID | FETCH-LOGICAL-c4775-d9b39266986b3012c7022332e1cd25efb3d053556adb51300a226c3fa511fe852 |
IngestDate | Sat Sep 28 08:06:14 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | heparin porous nanoparticles cell uptake metal-organic frameworks |
Language | English |
License | 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4775-d9b39266986b3012c7022332e1cd25efb3d053556adb51300a226c3fa511fe852 |
PMID | 25771896 |
ParticipantIDs | pubmed_primary_25771896 |
PublicationCentury | 2000 |
PublicationDate | June 3, 2015 |
PublicationDateYYYYMMDD | 2015-06-03 |
PublicationDate_xml | – month: 06 year: 2015 text: June 3, 2015 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Advanced healthcare materials |
PublicationTitleAlternate | Adv Healthc Mater |
PublicationYear | 2015 |
SSID | ssj0000651681 |
Score | 2.5182111 |
Snippet | The specific modification of the outer surface of the promising porous metal-organic framework nanocarriers (nanoMOFs) preserving their characteristic porosity... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1246 |
SubjectTerms | Animals Cell Line, Tumor Cell Survival Chemical Phenomena Coated Materials, Biocompatible - chemistry Cytokines - metabolism Delayed-Action Preparations Drug Delivery Systems Heparin - chemistry Humans Iron - chemistry Leukocytes, Mononuclear - drug effects Leukocytes, Mononuclear - metabolism Metal Nanoparticles - chemistry Mice Porosity Reactive Oxygen Species - metabolism |
Title | Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25771896 |
Volume | 4 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW68QIPiG8YA_mBt8qQuLGT8DZNgwrBnjq0t8mfa6ctnbaWh_6a_VTutZPUHUN8vESVnVZpzsn1sXN9LiHvijKrFShlZqusYoWGR7HOLGeOCwejh5Ze4dLAt0M5Piq-HIvjweAmyVpaLvR7s7pzX8n_oAptgCvukv0HZPsfhQb4DPjCERCG419hPHZYQ7BhrjUVBPF44a7nIKkxsRU3sGGFaHXOYu0mM_RdKtawUQ1Ml5OsuEXInx0i6LgvyV4tT8NJRl1hUbvrVMXudYkD03X2GCjf-Jf7CT5afdp5zB1zTR_-xzOrzk9D-wQuqm__Ol-pUAcc9w_N1PD7DN8nrPs_L3HbIgS2eMpq6n6odM0iFyG3KsYxF2IbxEnOuGzNwNtAXCR8q5KgChJE3hnto3usslO0FMixwnu0_E2gv7wI2ENggkG4ln_uveW-3XVtka2ywjh62K4GxZFe5LLKOy_QjH_YvBZ0mm6_f2vWEtTL5BF52E476F4E_DEZuOYJeZCYUT4lZ7-yia7ZRJFNdINNtGcT3WDTRxq5RFsuUeQSTbn0jBx9Opjsj1lbiYOZoiwFs7UGHS1lXUkNIwI3JUi_0Yi73Fh4qL0eWfQJElJZLfAFqQJVb0ZegZz3rhL8Odlu5o17SajS3HvjfK6sLGxZa5Hxsi4zbbThuravyIt4o04uo93KSXcLd37b85rcX7Nsl9zzQHb3BsTiQr8NiP0EuklwfA |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heparin-engineered+mesoporous+iron+metal-organic+framework+nanoparticles%3A+toward+stealth+drug+nanocarriers&rft.jtitle=Advanced+healthcare+materials&rft.au=Bellido%2C+Elena&rft.au=Hidalgo%2C+Tania&rft.au=Lozano%2C+Maria+Victoria&rft.au=Guillevic%2C+Mazheva&rft.date=2015-06-03&rft.eissn=2192-2659&rft.volume=4&rft.issue=8&rft.spage=1246&rft_id=info:doi/10.1002%2Fadhm.201400755&rft_id=info%3Apmid%2F25771896&rft_id=info%3Apmid%2F25771896&rft.externalDocID=25771896 |